JMDC Inc is a leading company with a unique business model. They specialize in offering comprehensive health data analysis and consulting services. Their innovative solutions enable healthcare professionals to make informed decisions and improve patient outcomes. By leveraging cutting-edge technology and partnering with industry experts, JMDC Inc is able to provide valuable insights and support to healthcare organizations. With a strong focus on data-driven solutions and continuous innovation, JMDC Inc strives to drive positive changes in the healthcare sector. Overall, JMDC Inc's business model revolves around delivering impactful healthcare data analysis and consulting services to empower the industry.

JMDC Inc is primarily active in the healthcare and data analysis industries.

The main competitors of JMDC Inc in the market are [insert names of competitors]. These companies operate in the same industry as JMDC Inc and offer similar products and services. As a professional stock website, we provide comprehensive information on JMDC Inc's competitors, financial performance, and market analysis. Stay informed about the competitive landscape and make well-informed investment decisions.

JMDC Inc is a leading company in the healthcare industry. It was founded in Japan in [year] and has since established a strong reputation for its data analysis and consulting services. With a focus on healthcare-related information, JMDC Inc offers valuable insights to various stakeholders within the industry, including medical institutions and pharmaceutical companies. The company has a rich history of delivering innovative solutions to improve healthcare outcomes and optimize operational efficiency. JMDC Inc's commitment to excellence and its continual growth make it a trusted partner in the healthcare sector.

Some significant milestones achieved by JMDC Inc include expanding its market presence, achieving consistent revenue growth, and introducing innovative healthcare solutions. JMDC Inc has successfully forged strategic partnerships with prominent healthcare providers, resulting in increased market share and improved accessibility to its services. With a strong commitment to delivering high-quality data analytics and software solutions, JMDC Inc has consistently witnessed revenue growth year after year. Furthermore, the company has been at the forefront of developing cutting-edge healthcare technologies, optimizing patient care, and enhancing overall healthcare efficiency. JMDC Inc continues to strive for excellence by embracing innovative solutions and expanding its reach in the healthcare industry.

JMDC Inc is primarily present in Japan.

JMDC Inc represents strong values and a clear corporate philosophy. With a focus on providing comprehensive healthcare information services, JMDC Inc aims to contribute to the improvement of medical care in Japan. The company is committed to promoting transparency, accessibility, and efficiency in the healthcare industry through their innovative solutions. By leveraging advanced technology and data analysis, JMDC Inc strives to enhance medical decision-making processes and drive positive patient outcomes. Their dedication to integrity, professionalism, and continuous growth underpin their commitment to delivering high-quality healthcare solutions. JMDC Inc's values and corporate philosophy are deeply rooted in their mission to create a healthier and more sustainable society.

Analysts currently set an average price target of 5,503.75 JPY for the JMDC stock (median: 5,508.00 JPY), implying +69.3 % versus the latest price. The consensus is based on 18 analyst ratings.

JMDC Analyst Price Targets 2026

18 analysts currently rate the JMDC stock: 17 recommend buying, 1 holding and 0 selling. For 2026, analysts expect JMDC to generate revenue of 52.04 B JPY and earnings per share of 116.66 JPY.

JMDC Analyst Price Targets 2026

Converted at the current exchange rate, the JMDC share trades at 17.66 EUR (3,290.00 JPY).

The JMDC share (4483.T) is listed on 3 stock exchanges, including: Frankfurt (6JM.F), München (6JM.MU).

JMDC Inc is a Japanese company that specializes in providing medical services and products. The company was founded in 1987 and has since expanded its business into various areas. Its main business fields include data analysis, health management, and medical products. JMDC Inc collects medical data and uses it to gain insights into diseases and treatment options. These insights are then used to develop new medical products and improve existing ones. The company also offers solutions for corporate health promotion, such as disease prevention programs, support for lifestyle changes, and promoting a healthy work environment. In addition, JMDC Inc offers a variety of medical products, including blood pressure measurement devices, diabetes monitoring devices, and allergy detection devices. Another product is the "Smart Seat," a sensor system that aims to improve people's sitting position and reduce back pain. A key part of JMDC Inc's business model is its joint venture with Aetna Japan, a leading provider of health insurance in Japan. This partnership allows JMDC Inc to expand its capabilities in health management and develop new products and services in close collaboration with Aetna Japan. Overall, JMDC Inc's business model focuses on gaining insights into diseases through data analysis and health management, and incorporating these insights into the development of new medical products and services. The company strives to play a leading role in promoting health and well-being in Japan and beyond.

The expected revenue of JMDC is 52.04 B JPY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of JMDC is 7.70 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of JMDC is currently 28.20. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the JMDC stock.

The price-to-sales ratio (P/S) of JMDC is currently 4.17. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the JMDC stock.

The Eulerpool Quality Score for JMDC is 5/10.

The ISIN of JMDC is JP3386690006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of JMDC is A2PWQC. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of JMDC is 4483.T. The ticker symbol is used to trade JMDC shares on the stock exchange.

Over the past 12 months, JMDC paid a dividend of 16.00 JPY . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, JMDC is expected to pay a dividend of 32.00 JPY.

The current dividend yield of JMDC is 0.49 %.

JMDC pays a dividend, distributed in the months of , , , .

JMDC paid dividends every year for the past 4 years.

For the upcoming 12 months, dividends amounting to 32.00 JPY are expected. This corresponds to a dividend yield of 0.97 %.

JMDC is assigned to the 'Health' sector.

To receive the latest dividend of JMDC from amounting to 16 JPY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, JMDC distributed 12 JPY as dividends.

The dividends of JMDC are distributed in JPY.